Health Care
UI, Cornell College create new dual-degree program in public health
Tuesday, May 23, 2017
The University of Iowa and Cornell College are teaming up to give students more opportunities, enhancing their prospects for careers and graduate study with a new dual-degree program in public health.
‘Forbes’ again ranks UI Health Care among ‘America’s Best Employers’
Thursday, May 11, 2017
For the third year in a row, “Forbes Magazine” has included University of Iowa Health Care in its annual listing of the nation’s top employers. In the 2017 “Forbes” rankings of “America’s Best Employers,” UI Health Care was named the No. 5 employer in the health care industry and No. 14 overall.
Mgbechi Erondu: A writer entering residency
Wednesday, May 10, 2017
Mgbechi Erondu received a Master of Fine Arts from the Iowa Writers’ Workshop in 2016 and will graduate this month from the University of Iowa Carver College of Medicine. She hopes to use both fields—fiction writing and medicine—to remind the world of how much people matter to one another.
UI College of Engineering students go above and beyond to help 8-year-old ride his bicycle
Thursday, April 27, 2017
Born without a right arm, Jonny Cole couldn’t ride a bike. Now, four UI undergrads in the Department of Biomedical Engineering have created a device that lets him ride with confidence.
UI student-owned business wins $100,000 at prestigious TCU start-up competition
Wednesday, April 26, 2017
HealthTech Solutions, a business founded by two University of Iowa students, both from Iowa, that makes it easier to connect organ donors with recipients, won the grand prize in a start-up venture competition sponsored by TCU.
UI to teach business and leadership skills to health care providers across Iowa
Monday, April 24, 2017
A new partnership among three University of Iowa colleges is training doctors in the ways of business. The Office of Healthcare Leadership Education (OHLE) will help Iowa health care providers better understand the economic forces at work in their practices.
How Vitamin C May Help Cancer Treatments Work Better
Friday, April 7, 2017
Researchers at the University of Iowa find that administering high doses of intravenous vitamin C to cancer patients is safe; the method may also boost the results of chemo and radiation therapy.
Financial math may help build a better HIV vaccine
Thursday, April 6, 2017
What do particle diffusion and stock price prediction have to do with building a better HIV vaccine? According to University of Iowa microbiologist Hillel Haim, you can apply concepts from both to predict the evolution of HIV surface proteins, making it easier to design effective vaccines.
UI hosts conference to save millions of lives globally
Wednesday, April 5, 2017
Millions of women die every year from the simple household task of cooking. The University of Iowa is hosting a group of internationally recognized experts at a conference, Women’s Health and the Environment: Going up in Smoke, to address the silent global crisis of cookstove smoke.
Device invented at UI helps patients communicate with caregivers
Monday, April 3, 2017
The Noddle, a device invented by UI-spinout company Voxello, is a technology that helps patients communicate with their health care providers, even though they are unable to speak.
UI researchers document how melanoma tumors form
Friday, March 31, 2017
University of Iowa researchers have documented for the first time how melanoma cells form tumors. The team reports the process is similar to that of breast cancer cells, and they have successfully screened for two antibodies that stopped tumor formation in both cancers. Results published in the journal “PLOS One.”
High-dose vitamin C proves safe and well-tolerated in brain and lung cancer trials
Thursday, March 30, 2017
Evidence is growing that adding high-dose, intravenous vitamin C to standard chemotherapy and radiation treatment may improve outcomes for patients with a wide range of cancers. Researchers with Holden Comprehensive Cancer Center at the University of Iowa report promising results from a phase 1 clinical trial.
Pagination